Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study

Onabotulinumtoxin A (onabotA) has shown efficacy in chronic migraine (CM), with good tolerability and a low rate of adverse effects, most of them not severe. The aim of this study is to evaluate tolerability and adverse effects of onabotA in clinical practice and to analyze if there is a relationshi...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Azorín, David, Martínez, Blanca, Gutiérrez, María, Ruiz-Piñero, Marina, Echavarría, Ana, Sierra, Álvaro, Guerrero, Ángel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783903/
https://www.ncbi.nlm.nih.gov/pubmed/36548746
http://dx.doi.org/10.3390/toxins14120850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783903/
https://www.ncbi.nlm.nih.gov/pubmed/36548746
http://dx.doi.org/10.3390/toxins14120850

Ejemplares similares